scholarly journals Strongyloides Hyper-Infection Syndrome and Ciliocytophthoria Mimicking Balantidium coli

2021 ◽  
Author(s):  
Moni Roy ◽  
Sharjeel Ahmad ◽  
Arif Sarwari
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Parasitic Infection ◽  
Interesting Case ◽  
Chronic Obstructive ◽  
Shortness Of Breath ◽  
Ciliated Cells ◽  
Obstructive Pulmonary Disease ◽  
Balantidium Coli

Ciliocytophthoria is a phenomenon where degenerated cells in infections or malignancy can present as ciliated cells on microscopy and so may be confused with ciliated parasitic infection. We present an interesting case of recurrent shortness of breath, misdiagnosed as chronic obstructive pulmonary disease exacerbations leading to unnecessary exposure to antimicrobials and steroids. The case was diagnosed as Strongyloides hyper-infection syndrome. Another finding worth mentioning was that ciliated cells noted on broncho-alveolar lavage were thought to be a co-infection with Balantidium coli but were later confirmed as ciliocytophthoria.

scholarly journals Platypnea: оne more type position shortness of breath

2020 ◽  
Vol 92 (3) ◽  
pp. 92-97
Author(s):  
L. I. Dvoretskiy ◽  
V. V. Rezvan
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Liver Diseases ◽  
Hepatopulmonary Syndrome ◽  
Diagnosis And Treatment ◽  
Chronic Obstructive ◽  
Shortness Of Breath ◽  
Severe Liver ◽  
Obstructive Pulmonary Disease ◽  
Cardiac Pathology

The article presents modern data on the causes of platypnea, methods of its diagnosis and treatment. The data on the development of platypnea syndrome are given not only in cardiac pathology, but also in severe liver diseases with the development of hepatopulmonary syndrome and chronic obstructive pulmonary disease of a severe course.

scholarly journals Use of a Cross-Sectional Survey in the Adult Population to Characterize Persons at High-Risk for Chronic Obstructive Pulmonary Disease

Healthcare ◽  
2019 ◽  
Vol 7 (1) ◽  
pp. 12
Author(s):  
Roy Pleasants ◽  
Khosrow Heidari ◽  
Jill Ohar ◽  
James Donohue ◽  
Njira Lugogo ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
High Risk ◽  
Pulmonary Disease ◽  
Tobacco Use ◽  
Respiratory Symptoms ◽  
Disease Burden ◽  
Chronic Obstructive ◽  
Shortness Of Breath ◽  
Obstructive Pulmonary Disease ◽  
Health Impairments

Rationale/Objective: The Behavioral Risk Factor Surveillance System (BRFSS) health survey has been used to describe the epidemiology of chronic obstructive pulmonary disease (COPD) in the US. Through addressing respiratory symptoms and tobacco use, it could also be used to characterize COPD risk. Methods: Four US states added questions to the 2015 BRFSS regarding productive cough, shortness of breath, dyspnea on exertion, and tobacco duration. We determined COPD risk categories: provider-diagnosed COPD as self-report, high-risk for COPD as ≥10 years tobacco smoking and at least one significant respiratory symptom, and low risk was neither diagnosed COPD nor high risk. Disease burden was defined by respiratory symptoms and health impairments. Data were analyzed using multiple logistic regression models with age as a covariate. Results: Among 35,722 adults ≥18 years, the overall prevalence of COPD and high-risk for COPD were 6.6% and 5.1%. Differences among COPD risk groups were evident based on gender, race, age, geography, tobacco use, health impairments, and respiratory symptoms. Risk for disease was seen early where 3.75% of 25–34 years-old met high-risk criteria. Longer tobacco duration was associated with an increased prevalence of COPD, particularly >20 years. Seventy-nine percent of persons ≥45 years-old with frequent shortness of breath (SOB) reported having or being at risk of COPD, reflecting disease burden. Conclusion: These data, representing nearly 18% of US adults, indicates those at high risk for COPD share many, but not all of the characteristics of persons diagnosed with the disease and demonstrates the value of the BRFSS as a tool to define lung health at a population level.

scholarly journals PREDICTORS OF SHORTNESS OF BREATH DURING STAIR CLIMB IN COMMUNITY-DWELLING INDIVIDUALS WITH COPD

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S264-S264
Author(s):  
Shweta Gore
Keyword(s):  
Physical Activity ◽  
Cardiovascular Disease ◽  
Chronic Obstructive Pulmonary Disease ◽  
Waist Circumference ◽  
Muscle Strength ◽  
Pulmonary Disease ◽  
Community Dwelling ◽  
Chronic Obstructive ◽  
Shortness Of Breath ◽  
Obstructive Pulmonary Disease

Abstract Dyspnea is the primary and most disabling symptoms seen in chronic obstructive pulmonary disease (COPD). Primary pathophysiological changes such as dynamic hyperinflation have been associated with the etiology of dyspnea in chronic obstructive pulmonary disease (COPD). However, since the experience of dyspnea “derives from interactions among multiple physiological, psychosocial and environmental factors”, a single correlate to accurately predict dyspnea has not been established. The purpose of this study was to identify factors that could predict shortness of breath during stair climb (SOB-SC) in community dwelling adults with COPD. We hypothesized that physical activity and muscle strength would significantly predict SOB-SC. Individuals with COPD who participated in the National Health and Nutrition Examination Survey (NHANES) between years 1999-2002 were selected for this study. Participants were excluded if they had significant mobility limitations. Socioeconomic, demographic variables, and clinical variables including BMI, physical activity, comorbidities, muscle strength, ankle brachial index, waist circumference and inflammatory markers were extracted. Logistic regression models were plotted with SOB-SC as the categorical dependent variable after assessing for collinearity using the forced-entry method. Individuals with COPD had a significantly greater proportion of SOB-SC (χ = 134.87, p < 0.001). Larger waist circumference (p = 0.002, CI = 0.04 -0.13), presence of cardiovascular disease (p = 0.001, CI = 0.76 -2.37) and Caucasian race were found to significantly predict SOB-SC after controlling for covariates. This study reinforces the importance of screening for cardiovascular disease and lifestyle modification in this population subgroup. Future studies examining differences in COPD severity are needed.

scholarly journals EXPRESS: Pulmonary Hypertension Due to Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease: A Patient Experience Study of Symptoms and Their Impact on Quality of Life

2021 ◽  
pp. 204589402110056
Author(s):  
Hillary Dubrock ◽  
Steven Nathan ◽  
Bryce B. Reeve ◽  
Nicholas Kolaitis ◽  
Stephen C. Mathai ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Hypertension ◽  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Pulmonary Disease ◽  
Patient Experience ◽  
Chronic Obstructive ◽  
Shortness Of Breath ◽  
Obstructive Pulmonary Disease ◽  
Group 3

Pulmonary hypertension (PH) resulting from chronic lung disease such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) is categorized by the World Health Organization (WHO) as Group 3 PH. To identify the symptoms and impacts of WHO Group 3 PH and to capture data related to the patient experience of this disease, qualitative research interviews were undertaken with 3 clinical experts and with 14 individuals with PH secondary to COPD or ILD. Shortness of breath, fatigue, cough, and swelling were the most frequently reported symptoms of PH due to COPD or ILD, and shortness of breath was further identified as the single most bothersome symptom for most patients (71.4%). Interview participants also described experiencing a number of impacts related to PH and PH symptoms, including limitations in the ability to perform activities of daily living and impacts on physical functioning, family life, and social life as well as emotional impacts, which included frustration, depression, anxiety, isolation, and sadness. Results of these qualitative interviews offer an understanding of the patient experience of PH due to COPD or ILD, including insight into the symptoms and impacts that are most important to patients in this population. As such, these results may help guide priorities in clinical treatment and assist researchers in their selection of patient-reported outcome measures for clinical trials in patients with PH due to COPD or ILD.

scholarly journals ASPECTS OF VERIFICATION OF RADIATION DIAGNOSTICS OF CHRONIC OBSTRUCTIVE LUNG DISEASE

2020 ◽  
Vol 3 (3(72)) ◽  
pp. 42-45
Author(s):  
Zh.A. Turdumatov ◽  
G.M. Mardieva
Keyword(s):  
Computed Tomography ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Chronic Obstructive Lung Disease ◽  
Chronic Obstructive ◽  
Shortness Of Breath ◽  
Obstructive Pulmonary Disease ◽  
Symptom Complex ◽  
Expiratory Air

During the examination of 60 patients with long-term (chronic) cough and shortness of breath using standard and digital radiography, as well as computed tomography, 21 patients were verified to have chronic obstructive pulmonary disease. Differentiated chronic obstructive pulmonary disease based on the clinical and radiological symptom complex, indicating damage to the small bronchi. A symptom of an expiratory "air trap" in combination with the expansion and deformation of the bronchi of various calibers, up to bronchioelectasis, was a diagnostic symptom for chronic obstructive pulmonary disease during computed tomography.

Early bronchodilatory response to the first dose of indacaterol/glycopyrronium as an additional individual predictor of their effectiveness in the treatment of chronic obstructive pulmonary disease

2020 ◽  
Vol 22 (4) ◽  
pp. 17-22
Author(s):  
N. V. Sharova ◽  
S. L. Grishaev ◽  
D. V. Cherkashin ◽  
S. V. Efimov ◽  
M. A. Kharitonov ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Clinical Signs ◽  
Chronic Obstructive ◽  
Shortness Of Breath ◽  
Obstructive Pulmonary Disease ◽  
Long Acting ◽  
The Impact

The effectiveness of the early bronchodilatory response of the first dose of a fixed double combination of long-acting bronchodilators of various classes indacaterol/glycopyrronium and long-acting anticholinergics glycopyrronium and Tiotropium in patients suffering from stable chronic obstructive pulmonary disease is compared. It was found that in all patients included in the study and suffering from chronic obstructive pulmonary disease, changes in functional respiratory indicators were accompanied by positive and comparable dynamics of clinical signs: a decrease in the severity of shortness of breath, the impact of the disease on the quality of life and increased tolerance to physical activity. It was found that the combination of indacaterol/glycopyrronium provides rapid, pronounced and prolonged bronchodilation in patients suffering from chronic obstructive pulmonary disease compared to the separate use of glycopyrronium and Tiotropium. Consistent use of glycopyrronium and salbutamol leads to maximum bronchodilation, which makes it advisable to separate the use of prolonged bronchodilators when initiating therapy for chronic obstructive pulmonary disease. Therefore, there is a clinical feasibility of taking not only fixed combinations of bronchodilators of different classes, but also their consistent use. The results of an early bronchodilatory response to the first dose of indacaterol/glycopyrronium can be used as an additional individual predictor of their effectiveness in the treatment of chronic obstructive pulmonary disease.

Sign in / Sign up

Export Citation Format

Share Document